Sesen Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sesen Bio's past years’ income statements indicate that its last revenue has increased compared to the previous period by 51% to $40,000,000. Profit margin reached -50%. Total operating expenses were $78,381,000.

Profit Margin

Sesen Bio, Inc. (NASDAQ:SESN): Profit margin
2013 1.33M -18.02M -1351.2%
2014 2.24M -34.15M -1522.78%
2015 990K -33.45M -3378.99%
2016 29.98M 1.89M 6.31%
2017 425K -29.02M -6830.35%
2018 0 -34.5M
2019 0 -179.12M
2020 11.23M -22.39M -199.33%
2021 26.54M -336K -1.27%
2022 40M -19.88M -49.71%

SESN Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
40M26.54M11.23M00425K29.98M990K2.24M1.33M
Cost of revenue
0000000000
Gross profit
40M26.54M11.23M00425K29.98M990K2.24M1.33M
Operating exp.
Research and development
38.59M25.31M29.19M24.66M14.07M12.51M13.47M26.33M26.70M13.78M
Selling and marketing
0000000000
Total operating expenses
78.38M54.70M43.49M36.87M25.7M20.58M28.21M36.18M35.17M17.81M
Operating income
-25.90M-8.54M-21.07M34.74M-34.5M-29.25M2.86M-35.19M-32.93M-16.47M
Other income (expenses), net
2.15M-60K125K-142.24M807K226K377K3.13M-1.22M-147K
Income before tax
-23.75M-8.60M-20.95M-107.5M-33.69M-29.02M1.89M-33.45M-34.15M-18.02M
Income tax expense
-3.87M-8.27M1.44M71.62M807K226K5K4.53M-473K1.25M
Net income
-19.88M-336K-22.39M-179.12M-34.5M-29.02M1.89M-33.45M-34.15M-18.02M
Earnings per share
Basic EPS
-1.99-0.03-3.79-39.4-11.17-22.241.8-35.23-46.65-1.17
Diluted EPS
-1.99-0.03-3.79-39.4-11.17-22.241.8-35.23-46.65-1.17
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source